研究疾病:
|
慢性阻塞性肺疾病
|
研究疾病代码:
|
|
Target disease:
|
Chronic obstructive pulmonary disease
|
Target disease code:
|
研究类型:
Study type:
|
干预性研究
Interventional study
|
研究设计:
Study design:
|
非随机对照试验
Non randomized control
|
研究所处阶段:
Study phase:
|
I期临床试验
Phase I clinical trial
|
研究目的:
|
观察“冬夏并治”穴位敷贴疗法对慢性阻塞性肺疾病的临床症状、年感冒次数、年发作次数、生活质量的影响,评价“冬夏并治”穴位敷贴治疗慢性阻塞性 肺疾病的临床疗效,为申请相关专利,进行院内制剂开发打下基础。
|
Objectives of Study:
|
To observe the effect of "combined treatment of winter and summer" acupoint application therapy on the clinical symptoms, annual cold frequency, annual attack frequency, and quality of life of chronic obstructive pulmonary disease, and to evaluate the clinical efficacy of "combined treatment of winter and summer" acupoint application therapy for chronic obstructive pulmonary disease, so as to lay a foundation for applying for relevant patents and developing hospital preparations.
|
药物成份或治疗方案详述:
|
|
Description for medicine or protocol of treatment in detail:
|
|
纳入标准:
|
(1)符合 2013 年《慢性阻塞性肺疾病诊治指南》标准并处于稳定期慢性阻塞性肺疾病患者。
(2)符合本病中医诊断及辨证标准的。
(3)年龄 40-80 岁,获得知情同意书(知情同意过程:遵循完全告知、充分理解、自主选择的原则,本临床研究由本研究的研究者按照诊断标准、纳排标准等选取符合本研究的受试者,并向受试者详细介绍本研究内容、获取其知情同意及指导其签署知情同意书等,以保证医患双方的利益,在此过程中应详细解答患者提出的各种问题)。
(4)依从性较好,配合治疗,可以接受电话随访,未参加其他临床研究者。
(5)在川北医学院附属医院就诊患者。
|
Inclusion criteria
|
(1) Patients with chronic obstructive pulmonary disease who meet the criteria of the Guidelines for the Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease (2013) and are in stable stage.
(2) Conforming to the criteria of TCM diagnosis and syndrome differentiation of the disease.
(3) Age 40-80, Obtaining Informed Consent (Informed consent process: follow the principle of full disclosure, full understanding, and independent choice. In this clinical study, the researcher of this study selects the subjects who meet this study according to the diagnostic criteria, inclusive criteria, etc., and introduces the content of this study to the subjects in detail, obtains their informed consent, and guides them to sign the informed consent form, so as to ensure the interests of both doctors and patients. In this process, various questions raised by the patients should be answered in detail.).
(4) Good compliance, with treatment, can accept telephone follow-up, did not participate in other clinical researchers.
(5) See the patient in the Affiliated Hospital of North Sichuan Medical College.
|
排除标准:
|
(1)不符合 2013 年《慢性阻塞性肺疾病诊治指南》标准或不处于稳定期慢性阻塞性肺疾病患者。
(2)年龄在 40 岁以下或 80 岁以上,妊娠及哺乳期妇女。
(3)过敏体质或对多种药物过敏者。
(4)研究中有任何不适宜入选的情况(包括:COPD 极重度患者、合并有心血管、肝肾及造血系统等严重原发性疾病、精神病患者、妊娠、哺乳期妇女及其他严重影响生存质量的严重疾患)。
|
Exclusion criteria:
|
(1) Patients with chronic obstructive pulmonary disease who do not meet the criteria of the 2013 Guidelines for the Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease or are not in a stable period.
(2) Women under 40 years old or over 80 years old, pregnant and lactating.
(3) Allergic constitution or allergy to multiple drugs.
(4) There are any cases that are not suitable for inclusion in the study (including: patients with very severe COPD, patients with serious primary diseases such as cardiovascular disease, liver and kidney disease and hematopoietic system, psychiatric patients, pregnant and lactating women, and other serious diseases that seriously affect the quality of life).
|
研究实施时间:
Study execute time:
|
从From
2022-01-01
至To
2025-01-01
|
征募观察对象时间:
Recruiting time:
|
从From
2022-11-01
至To
2024-11-01
|